Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant

Background Severe primary graft dysfunction (PGD) is the leading cause of early death after heart transplant. Aim To examine the outcomes of heart transplant recipients who received venoarterial extracorporeal membrane oxygenation (VA‐ECMO) for severe PGD. Methods We reviewed electronic health recor...

Full description

Saved in:
Bibliographic Details
Published in:Clinical transplantation 2019-05, Vol.33 (5), p.e13538-n/a
Main Authors: Jacob, Samuel, Lima, Brian, Gonzalez‐Stawinski, Gonzalo V., El‐Sayed Ahmed, Magdy M., Patel, Parag C., Belli, Erol V., Makey, Ian A., Thomas, Mathew, Landolfo, Kevin, Landolfo, Carolyn, Leoni Moreno, Juan Carlos, Yip, Daniel S., Pham, Si M.
Format: Article
Language:English
Subjects:
clinical
extracorporeal membrane oxygenation
heart/ventricular assist devices
organ procurement and transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Severe primary graft dysfunction (PGD) is the leading cause of early death after heart transplant. Aim To examine the outcomes of heart transplant recipients who received venoarterial extracorporeal membrane oxygenation (VA‐ECMO) for severe PGD. Methods We reviewed electronic health records of adult patients who underwent heart transplant from November 2005 through June 2015. We defined severe PGD according to International Society for Heart and Lung Transplantation consensus statements. Results Of 1030 heart transplant patients, 31 (3%) had severe PGD and required VA‐ECMO. The mean (range) age was 59 (43‐69) years. Fifteen patients (48%) underwent prior sternotomy and 10 (32%) received a left ventricular assist device as a bridge to transplant. Severe PGD manifested as failure to wean from cardiopulmonary bypass in 20 patients (65%) and as severe hemodynamic instability in the immediate postoperative period in 10 (32%), including cardiac arrest in 3 (10%). Twenty‐five patients (81%) were successfully weaned from VA‐ECMO, and 19 (61%) were discharged; the other 12 (39%) died. Conclusions Although VA‐ECMO is a common method for providing mechanical circulatory support to patients with PGD, multicenter studies are needed to assess factors associated with successful outcomes and improved survival of these patients.
ISSN:0902-0063
1399-0012
DOI:10.1111/ctr.13538